IMO with the small steps they try to transmit the feeling that it was the last rise. Its like David vs Goliath. What is, lets say a billion? Pfizer has already overtaken RAP. IMO I personally think David has good chances to anger Goliath. We have a weak sh register. But on the other hand a looooot of retail holders. You awaited to own a company who is a lifechanging opportunity? Here we are. If not RAP which other company is closer? As I say, I very Welcome Pfizer. But as a Cornerstone shareholder or Partner. Lets do it togheter. Overtake Raps as a subsidiary company.
all IMO and perception. At asx my strategy is keep till the end. ;-) bio dollar company, TO or chapter 11. : - ) absolutely no investment advice. Just my opinion.
- Forums
- ASX - By Stock
- RAP
- Ann: Pfizer raises scheme consideration to A$0.208 per share
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-60
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online